Strata Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
449
-10
-2% -$5.43K 0.06% 85
2025
Q4
$266K Buy
459
+19
+4% +$10.7K 0.07% 78
2025
Q3
$213K Buy
+440
New +$205K 0.06% 94
2025
Q1
Sell
-422
Closed -$220K 78
2024
Q4
$220K Buy
422
+26
+7% +$14.3K 0.07% 76
2024
Q3
$245K Buy
396
+32
+9% +$18.9K 0.08% 68
2024
Q2
$201K Sell
364
-38
-9% -$21.8K 0.07% 75
2024
Q1
$234K Buy
+402
New +$226K 0.08% 68

Other funds holding TMO

Strata Wealth Advisors's TMO Position: Q1 2026 in Review

Strata Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 2.2% in Q1 2026, selling an estimated $5.43K and leaving 449 shares worth $221K. The position accounts for 0.06% of the portfolio, ranked #85.

Strata Wealth Advisors first reported a position in TMO in Q1 2024 and has held it in 7 quarters since. The position peaked at $266K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Strata Wealth Advisors held 449 shares of Thermo Fisher Scientific worth $221K as of Q1 2026.
  • Strata Wealth Advisors sold 10 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.43K.
  • Thermo Fisher Scientific made up 0.06% of Strata Wealth Advisors's portfolio in Q1 2026, its #85 holding.
  • Strata Wealth Advisors first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 7 quarters since.
  • Strata Wealth Advisors's Thermo Fisher Scientific position peaked at $266K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Strata Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.